13F-HR filed by ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 114 holding rows worth $5,064,526,267.
- Accession
- 0001172661-24-003539
- Filer
- CIK 1055951
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 115 entries on the cover page, a total value of $5,064,526,267 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,064,526,267 with VALUE read as dollars as filed, 13F file number 028-06774. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerORBIMED CAPITAL LLC028-10410
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SINOVAC BIOTECH LTD | P8696W104 | SHS | 2,718,735 | $340,000,000 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 337,600 | $305,656,288 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 15,021,721 | $270,541,195 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 3,273,000 | $252,053,730 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 493,100 | $219,355,535 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 900,900 | $208,846,638 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 7,959,538 | $186,014,403 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 1,316,000 | $162,920,800 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 1,173,300 | $156,084,099 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 2,979,828 | $124,824,995 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 2,372,333 | $113,065,391 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 646,000 | $102,068,000 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 269,000 | $91,527,250 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 168,100 | $91,086,666 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 209,100 | $89,921,364 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 1,785,571 | $80,475,685 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 9,240,887 | $78,639,948 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 5,779,071 | $75,127,923 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 687,500 | $74,449,375 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 132,000 | $72,996,000 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 151,000 | $70,776,720 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 1,707,331 | $64,315,159 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 448,200 | $61,703,694 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 250,300 | $60,822,900 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 795,900 | $60,098,409 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 1,268,734 | $57,981,144 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,280,800 | $57,367,032 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 112,000 | $57,037,120 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 3,027,328 | $56,156,934 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 174,100 | $54,575,127 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 7,619,135 | $51,886,309 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,302,800 | $49,975,408 | dollars as filed | |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 2,605,615 | $49,819,359 | dollars as filed | |
| XTANT MED HLDGS INC | 98420P308 | COM NEW | 73,114,592 | $46,062,193 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 812,906 | $44,043,247 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 134,900 | $42,149,505 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 3,229,977 | $41,763,603 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 10,909,256 | $41,564,265 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 2,861,801 | $41,381,642 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 2,252,987 | $40,441,117 | dollars as filed | |
| INTEGER HLDGS CORP | 45826H109 | COM | 349,221 | $40,436,300 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,925,300 | $39,526,409 | dollars as filed | |
| GERON CORP | 374163103 | COM | 8,930,252 | $37,864,268 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 862,362 | $33,623,494 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 289,900 | $32,868,862 | dollars as filed | |
| 0 | 000000000 | 0 | 12,048,773 | $32,149,678 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 704,842 | $28,940,813 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 706,475 | $28,859,504 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 672,416 | $28,409,576 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 3,406,335 | $25,751,893 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 708,400 | $24,999,436 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 675,872 | $24,453,049 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 5,559,528 | $24,183,947 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 22,800 | $23,963,484 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 2,021,424 | $23,650,661 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 2,006,381 | $23,314,147 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 6,512,866 | $22,795,031 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 22,362,850 | $22,362,850 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 612,500 | $20,867,875 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 2,320,102 | $20,648,908 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,147,655 | $20,015,103 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 4,001,711 | $17,647,546 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 379,130 | $14,918,766 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 1,500,000 | $14,745,000 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 11,447,140 | $13,851,039 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 4,316,824 | $13,641,164 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 6,943,654 | $12,637,450 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 4,180,768 | $12,375,073 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 768,638 | $12,290,522 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 2,457,542 | $11,550,447 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,894,462 | $11,423,606 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 3,322,488 | $10,964,210 | dollars as filed | |
| SOLVENTUM CORP COM SHS | 83444M101 | Stock | 200,000 | $10,576,000 | dollars as filed | call |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 6,475,291 | $10,489,971 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 5,846,100 | $9,821,448 | dollars as filed | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 6,405,098 | $9,287,392 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 156,100 | $9,236,437 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 1,074,382 | $8,949,602 | dollars as filed | |
| TURNSTONE BIOLOGICS CORP | 90042W100 | COM | 3,099,265 | $8,120,074 | dollars as filed | |
| PASSAGE BIO INC | 702712100 | COM | 10,124,576 | $8,040,938 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 50,000 | $7,900,000 | dollars as filed | call |
| PROGYNY INC COM | 74340E103 | Stock | 259,900 | $7,435,739 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 250,000 | $6,995,000 | dollars as filed | call |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,513,058 | $6,990,328 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 3,539,358 | $5,839,941 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 570,300 | $5,657,376 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 29,966 | $5,502,956 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 2,133,405 | $5,323,485 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 492,670 | $4,911,920 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 125,000 | $4,908,750 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 800,000 | $4,728,000 | dollars as filed | |
| BIOMX INC | 09090D103 | COM | 13,773,653 | $4,629,325 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,529,115 | $4,556,763 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,355,352 | $4,445,555 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 7,133,515 | $4,137,439 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 250,000 | $3,232,500 | dollars as filed | call |
| MERUS N V | N5749R100 | COM | 50,000 | $2,958,500 | dollars as filed | call |
| INVIVYD INC | 00534A102 | COMMON STOCK | 2,425,800 | $2,668,380 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,000,000 | $2,640,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 600,000 | $2,544,000 | dollars as filed | call |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 941,275 | $2,541,443 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 133,200 | $2,369,628 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 26,100 | $2,148,813 | dollars as filed | |
| CHEMOMAB THERAPEUTICS LTD | 16385C104 | SPONSORED ADS | 2,241,273 | $2,045,162 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 287,100 | $2,029,797 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 1,141,200 | $1,814,508 | dollars as filed | |
| APOLLOMICS INC | G0411D107 | COM | 8,565,456 | $1,806,455 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 448,891 | $1,795,564 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 113,500 | $1,274,605 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,927,000 | $1,156,200 | dollars as filed | |
| LAKESHORE BIOPHARMA CO LTD | G9845F109 | COM | 1,404,280 | $909,833 | dollars as filed | |
| TRAWS PHARMA INC COM NEW | 68232V801 | Stock | 1,045,261 | $466,918 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 80,420 | $180,945 | dollars as filed | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R308 | COM | 18,023 | $152,294 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-24-003539 | this filing | 2024-08-14 | acceptance time not in the bulk data set |